Incidence and mortality of neuroblastoma in Canada compared with other childhood cancers

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Cancer Causes and Control

• Publication date

  1997-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1023/A:1018483405637PMID 9328197
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Childhood Cancer

  2020cited by this paper
• Cancer Incidence in Five Continents

  1997cited by this paper
• This Battle Which I Must Fight. Cancer in Canada’s Children and Teenagers.

  1997cited by this paper
• Screening for neuroblastoma.

  1996cited by this paper
• A population-based study of the usefulness of screening for neuroblastoma.

  1996cited by this paper
• Trends in cancer incidence among children in the U.S.

  1996cited by this paper
• Childhood cancer

  1995cited by this paper
• Neuroblastoma: A clinical challenge and biologic puzzle

  1995cited by this paper
• Incidence of cancer in children in the United States. Sex‐, race‐, and 1‐year age‐specific rates by histologic type

  1995cited by this paper
• Screening for neuroblastoma in north america. Preliminary results of a pathology review from the quebec project

  1995cited by this paper
• Prostate cancer: the epidemiologic perspective.

  1994cited by this paper
• The Canadian Childhood Cancer Control Program.

  1994cited by this paper
• Screening for neuroblastoma (NB) in North America: the Quebec Project.

  1994cited by this paper
• Neuroblastoma: a 32-year population-based study--implications for screening.

  1993cited by this paper
• Trends in neuroblastoma in Great Britain: incidence and mortality, 1971-1990.

  1993cited by this paper
• A population-based study of neuroblastoma incidence, survival, and mortality in North America.

  1992cited by this paper
• International variations in the incidence of neuroblastoma

  1992cited by this paper
• Neuroblastoma represents distinct clinical-biologic entities: a review and perspective from the Quebec Neuroblastoma Screening Project.

  1992cited by this paper
• Molecular Basis of Clinical Heterogeneity in Neuroblastoma

  1992cited by this paper
• Screening for neuroblastoma.

  1991cited by this paper
• Neuroblastoma screening data. An epidemiologic analysis.

  1991cited by this paper
• Decrease in childhood neuroblastoma death in Japan.

  1990cited by this paper
• Screening for neuroblastoma at 3 weeks of age: methods and preliminary results from the Quebec Neuroblastoma Screening Project.

  1990cited by this paper
• Improvements in survival from childhood cancer: results of a population based survey over 30 years

  1988cited by this paper
• A classification scheme for childhood cancer

  1988cited by this paper
• A classification scheme for childhood cancer

  1987cited by this paper
• Neuroblastoma: the case for screening infants in North America.

  1987cited by this paper
• The incidence and epidemiologic characteristics of neuroblastoma in the United States.

  1987cited by this paper
• Three years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma.

  1987cited by this paper
• Medical and drug risk factors associated with neuroblastoma: a case-control study.

  1987cited by this paper
• Epidemiological investigations on neuroblastomas in Denmark 1943-1980.

  1986cited by this paper
• Neuroblastoma. Mass screening for early detection and its prognosis

  1984cited by this paper
• Cancer incidence in five continents.

  1976cited by this paper
• Catecholamine metabolism in neuroblastoma.

  1968cited by this paper
• NEUROBLASTOMA AND CATECHOLAMINE EXCRETION

  1961cited by this paper

• Liver‐Related Late Effects in Long‐Term Survivors of High‐Risk Neuroblastoma: Insights From a Comprehensive Prospective Follow‐Up Study

  2026influential citation
• High-risk neuroblastoma with NF1 loss of function is targetable using SHP2 inhibition

  2022cites this paper
• Association Between Participation in Clinical Trials and Overall Survival Among Children With Intermediate- or High-risk Neuroblastoma

  2021cites this paper
• PCNP is a Novel Regulator of Neuroblastomas Cancer

  2019cites this paper
• The who, when, and why of primary adrenal malignancies: Insights into the epidemiology of a rare clinical entity

  2018cites this paper
• Exploitation of the Apoptosis-Primed State of MYCN-Amplified Neuroblastoma to Develop a Potent and Specific Targeted Therapy Combination

  2016cites this paper
• Transcription regulatory networks in medulloblastoma.

  2015cites this paper
• Nanomedicine as an innovative therapeutic strategy for pediatric cancer

  2015cites this paper
• Oncolytic Poliovirus Therapy in a Mouse Model of Neuroblastoma: Preclinical Data Analysis and Future Studies

  2012influential citation
• Trends in incidence of childhood cancer in Canada, 1992-2006.

  2012cites this paper
• Application of a national administrative case definition for the identification of pre-existing diabetes mellitus in pregnancy.

  2012cites this paper
• Long‐term hepatic outcomes in survivors of stage 4S and 4 neuroblastoma in infancy

  2012cites this paper
• Comparison of genomic profiles in human neuroblastic SH-SY5Y and substrate-adherent SH-EP cells using array comparative genomic hybridization

  2011cites this paper
• Chronic Diseases and Injuries in Canada

  2011cites this paper
• PKC inhibition increases gap junction intercellular communication and cell adhesion in human neuroblastoma

  2010cites this paper
• Examining different levels of prevention of birth defects and fetal alcohol spectrum disorder.

  2009cites this paper
• The epidemiology of neuroblastoma: a review.

  2009cites this paper
• Toxicity of a traditional Chinese medicine, Ganoderma lucidum, in children with cancer.

  2008cites this paper
• AKT pathway in neuroblastoma and its therapeutic implication

  2008cites this paper
• Three-Dimensional Segmentation of the Tumor in Computed Tomographic Images of Neuroblastoma

  2006cites this paper
• Mortality rate of adrenocortical tumors in children under 15 years of age in Curitiba, Brazil

  2006cites this paper
• Urinary catecholamine metabolites: Capillary gas chromatography method and experience with 12 cases of neuroblastoma

  2005cites this paper
• A 2-year-old boy with diarrhoea and failure to thrive.

  2003cites this paper
• Folic acid food fortification is associated with a decline in neuroblastoma

  2003cites this paper
• Screening of infants and mortality due to neuroblastoma.

  2002cites this paper
• Perinatal factors and risk of neuroblastoma.

  2001cites this paper
• Neuroblastoma in Europe: differences in the pattern of disease in the UK. SENSE. Study group for the Evaluation of Neuroblastoma Screening in Europe.

  1998cites this paper
• The evolution of the diagnosis and understanding of primitive and embryonic neoplasms in children: living through an epoch.

  1998cites this paper
• SCREENING OF INFANTS AND MORTALITY DUE TO NEUROBLASTOMA

  year unknowncites this paper